ARCHIVES

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Trial Needed Of PSA To Determine Patients To Test, Chabner Says

March 5, 1993

Emory’s Winship Cancer Institute Wins NCI Cancer Center Designation

April 17, 2009

In Brief: ACCC Honors Henry Lynch; Gunderson Names Chair, Mayo Oncology Department

October 11, 1996

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

November 7, 1980

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986

Robert Cook-Deegan’s Viewers’ Guide To the Super Bowl of Gene Patent Cases

March 14, 2014